Foamix Pharmaceuticals Ltd.
(NASDAQ : FOMX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-3.02%172.750.4%$312.80m
AMRNAmarin Corporation Plc Sponsored ADR
-6.00%16.912.0%$244.81m
JAZZJazz Pharmaceuticals Plc
-1.62%141.172.2%$120.91m
PRGOPerrigo Co. Plc
-4.30%59.936.8%$105.96m
GWPHGW Pharmaceuticals PLC Sponsored ADR
1.73%124.846.3%$61.48m
MNKMallinckrodt Plc
-3.62%20.7521.1%$55.15m
ENDPEndo International Plc
-0.26%11.578.9%$50.42m
ICLRICON Plc
-1.64%139.634.1%$44.84m
HZNPHorizon Pharma plc
-2.04%19.657.4%$42.45m
UTHRUnited Therapeutics Corporation
-2.95%109.4414.4%$40.43m
SAGESAGE Therapeutics, Inc.
-3.02%102.689.6%$39.65m
ICPTIntercept Pharmaceuticals, Inc.
-4.26%102.2618.6%$38.77m
CTLTCatalent Inc
-2.68%36.312.4%$37.78m
PTLAPortola Pharmaceuticals, Inc.
0.73%20.687.7%$32.06m
ZGNXZogenix, Inc.
-2.43%42.5510.0%$25.36m

Company Profile

Foamix Pharmaceuticals Ltd. is a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.